CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, a leader in the development of innovative gene therapies for severe genetic disorders, announced today that Nick Leschly, chief executive officer, is scheduled to present at the Leerink Swann 2012 Global Healthcare Conference on Wednesday, February 15, 2012 at 2:15PM EST at the Waldorf Astoria Hotel in New York City.
